# Tubulis: Biotechnology, Munich, Germany

> Tubulis: Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment. Based in Munich, Germany. Founded 2012.

Source: https://millionrounds.com/startup/tubulis (Millionrounds; every figure on the page links to its filing or article)

Germany · [Biotechnology startup](https://millionrounds.com/companies)

# Tubulis

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

Funding reported Last round: Series B

Biotechnology Munich, Germany

Company summary

- **Founded:** 2012 14 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** 400.6M as listed, currency not stated
- **Last round:** Series B Mar 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Tubulis has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Tubulis raised

Funding, as reported

Reported in all **400.6M** in the source's currency

Rounds **4**

Last round **Series B**

Last round date **Mar 2024**

Investors listed **13**

## Founders and team

From Tubulis's own website: 56 on the team.

- **Andreas Montag** Vice President Finance
- **Dr. Annette Vogl** Vice President Biology and Translational Research
- **Dr. Armin Weidmann** Senior Vice President Quality
- **Dr. Marc-André Kasper** Vice President Chemistry and Early Development
- **Dr. Moetaz B. Albizem** Senior Vice President and Head of Clincal Operations
- **Dr. Olivier Marcq** Senior Vice President CMC
- **Dr. Yariv Houvras** Vice President Clinical and Translational Development
- **Mary Ann Lumiqued** Vice President Program Management
- **Ramola Bhandarkar** Senior Vice President Regulatory Affairs
- **Bettina Deisenrieder** Executive Assistant to the CEO
- **Dr. Dominik Schumacher** CEO
- **Adriane Krahe** Global Head of HR
- **Dr. Bernhard Seehaus** Global Head of Intellectual Property
- **Eckart Frehe** Head of IT
- **Anastasia Kazanis** Senior Operations Manager
- **Andrea Mathieu** Financial Operations Specialist
- **Arijana Popadic** Office Manager
- **Christina Bauer** HR Manager

And 38 more on the team.

## On 4 portfolio pages

Investors who name them

- [OCCIDENT](https://millionrounds.com/fund/occident)
- [Andera Partners](https://millionrounds.com/fund/andera-partners)
- [Nextech Invest](https://millionrounds.com/fund/nextech-invest)
- [Ascenta Capital](https://millionrounds.com/fund/ascenta-capital)

Each firm lists Tubulis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in Germany

Startups like it

- [**AtaiBeckley** Berlin](https://millionrounds.com/startup/ataibeckley)
- [**Sanity Group** Berlin · founded 2018](https://millionrounds.com/startup/sanity-group)
- [**Lux Biosciences** Frankfurt · founded 2005](https://millionrounds.com/startup/lux-biosciences)
- [**Emergence Therapeutics** Duisburg · founded 2019](https://millionrounds.com/startup/emergence-therapeutics)
- [**ETHRIS** Planegg · founded 2009](https://millionrounds.com/startup/ethris)
- [**AiCuris** Wuppertal · founded 2006](https://millionrounds.com/startup/aicuris)
- [**SuppreMol** Martinsried · founded 2002](https://millionrounds.com/startup/suppremol)
- [**AMSilk** Neuried · founded 2008](https://millionrounds.com/startup/amsilk)

## Is this your company?

Add your raise, your deck and your story, and put Tubulis in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)